Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Couillard

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
The European Respiratory Journal|July 1, 2022
The alarmin(g) effect of interleukin-5 blockade on residual eosinophil function is of clinical consequenceSimon Couillard
The European Respiratory Journal|July 3, 2021
Antibiotics for asthma attacks: masking uncertaintySanjay Ramakrishnan, Simon Couillard
American Journal of Respiratory and Critical Care Medicine|June 30, 2025
Baseline Membrane Thickness in Asthma: Where Type-2 Inflammation Meets Remodeling?James Melhorn, Simon Couillard
Chest|June 9, 2023
Predicting On-Biologic Remission in Asthma: Insight From the AirwaysSimon Couillard, Andréanne Côté
Chest|August 10, 2025
In the Land of Asthma, 4 Risk Factors to Rule Them AllSimon Couillard, Sanjay Ramakrishnan
The European Respiratory Journal|April 24, 2025
Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?Mohamed-Ilias Kourid, Simon Couillard
Respirology (Carlton, Vic.)|February 1, 2022
Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthmaSimon Couillard, Ian D Pavord
The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2025
Biomarker Suppression in Asthma: How Low Can You Go?Joël St-Pierre, Simon Couillard
Respirology (Carlton, Vic.)|May 6, 2026
Microbial Phenotyping in COPD Exacerbations: One Step Closer to Precision-Based ManagementCarlos Andrés Celis-Preciado, Simon Couillard
The European Respiratory Journal|February 19, 2026
Dupilumab and lymphoma risk in asthmaCarlos Andres Celis-Preciado, Simon Couillard
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
The European Respiratory Journal|July 1, 2022
The alarmin(g) effect of interleukin-5 blockade on residual eosinophil function is of clinical consequenceSimon Couillard
The European Respiratory Journal|July 3, 2021
Antibiotics for asthma attacks: masking uncertaintySanjay Ramakrishnan, Simon Couillard
American Journal of Respiratory and Critical Care Medicine|June 30, 2025
Baseline Membrane Thickness in Asthma: Where Type-2 Inflammation Meets Remodeling?James Melhorn, Simon Couillard
Chest|June 9, 2023
Predicting On-Biologic Remission in Asthma: Insight From the AirwaysSimon Couillard, Andréanne Côté
Chest|August 10, 2025
In the Land of Asthma, 4 Risk Factors to Rule Them AllSimon Couillard, Sanjay Ramakrishnan
The European Respiratory Journal|April 24, 2025
Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?Mohamed-Ilias Kourid, Simon Couillard
Respirology (Carlton, Vic.)|February 1, 2022
Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthmaSimon Couillard, Ian D Pavord
The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2025
Biomarker Suppression in Asthma: How Low Can You Go?Joël St-Pierre, Simon Couillard
Respirology (Carlton, Vic.)|May 6, 2026
Microbial Phenotyping in COPD Exacerbations: One Step Closer to Precision-Based ManagementCarlos Andrés Celis-Preciado, Simon Couillard
The European Respiratory Journal|February 19, 2026
Dupilumab and lymphoma risk in asthmaCarlos Andres Celis-Preciado, Simon Couillard
Pageof 7